Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Voglibose 0.2mg
You Searched
Voglimera 0.2 Tablet DT
₹55
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
In Treatment of Type 2 diabetes mellitus : Voglimera 0.2 Tablet DT is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Voglimera 0.2 Tablet DT will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Voglimera Tablet DTThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Voglimera Skin rash Flatulence Abdominal pain Diarrhea
How to use Voglimera Tablet DTFollow your doctor's guidance regarding the dose and duration of this medication. Dissolve it in a glass of water before taking it. Voglimera 0.2 Tablet DT is to be taken empty stomach.
How Voglimera Tablet DT works Voglimera 0.2 Tablet DT is an anti-diabetic medicine. It inhibits the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meals.
Unsafe: Avoid consuming alcohol with Voglimera 0.2 Tablet DT as it is deemed unsafe.
Voglimera 0.2 Tablet DT is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Voglimera 0.2 Tablet DT is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Voglimera 0.2 Tablet DT does not usually affect your ability to drive.
Voglimera 0.2 Tablet DT should be used with caution in patients with severe kidney disease. Dose adjustment of Voglimera 0.2 Tablet DT may be needed. Doctor consultation is advised.
Voglimera 0.2 Tablet DT should be used with caution in patients with severe liver disease. Dose adjustment of Voglimera 0.2 Tablet DT may be needed. Doctor consultation is advised.
If you forget a dose of Voglimera 0.2 Tablet DT , simply continue with your regular schedule and do not take a double dose.
Ward No. 7, Buddi Siswan Road, District - Mohali, Kurali- 140103, Punjab, India
Voglibose (21 Sept. 2021)
CiplaMed.Voglibose (21 Sept. 2021)
Pattanaik SR, Shah P, Baker A, et al. Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus. Journal of Clinical and Diagnostic Research. 2018;12(4):OE08-OE12 (21 Sept. 2021)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An alpha glucosidase inhibitor. J Clin Diagn Res. 2013;7(12):3023-3027 (21 Sept. 2021)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (12 Mar. 2019)
Voglibose (07 Aug. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.